Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Cancer statistics, 2022
2022 Standout
Recent Advances in Breast Cancer-Related Lymphedema of the Arm: Lymphatic Pump Failure and Predisposing Factors
2009
Cancer statistics, 2023
2023 Standout
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
2010
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
2002
Cancer Statistics, 2021
2021 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Cardiac complications in childhood cancer survivors treated with anthracyclines
2015
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells
2015
Acute lymphoblastic leukaemia
2008
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
2000
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
2007
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
2008
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Cytogenetics in acute leukemia
2003
Childhood acute lymphoblastic leukaemia – current status and future perspectives
2001
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
2013
Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
2000 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Head and neck cancer
2008 Standout
Cellular Senescence in Cancer and Aging
2007 Standout
Inherited defects in lymphocyte cytotoxic activity
2010
The Epigenomics of Cancer
2007 Standout
Hypermethylation of tumor suppressor genes in cancer
1999
Relapsed childhood acute lymphoblastic leukaemia
2013
Epigenetics in Cancer
2008 Standout
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
2009
Peripheral blood cell counts in infants with Down's syndrome
1996
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
2001
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Malignant Gliomas in Adults
2008 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Clinical significance of early T‐cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99‐15
2011
Cancer-epigenetics comes of age
1999 Standout
INK4a/ARF: A multifunctional tumor suppressor locus
2005
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Decitabine—Bedside to bench
2006
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Childhood Leukemias
1995
Stem cell origins of leukaemia and curability
1993
DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development
1999 Standout
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
2010 StandoutNobel
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Down's syndrome
2003 Standout
Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
1995
Prevention of Anthracycline-Induced Cardiotoxicity
2014
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults
2011
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
2008
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Histone Deacetylase Inhibitors as Anticancer Drugs
2017
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
2012
Pretherapeutic Morbidity in the Prognostic Staging of Acute Leukemia
1979
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
2003
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The Tumor Lysis Syndrome
2011 Standout
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
2012
A gene hypermethylation profile of human cancer.
2001 Standout
Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia
1986
The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
1999
Cardioprotective interventions for cancer patients receiving anthracyclines
2011
Cytokine Storm
2020 Standout
The Will Rogers Phenomenon
1985 Standout
Hypoxic Stress Induces Dimethylated Histone H3 Lysine 9 through Histone Methyltransferase G9a in Mammalian Cells
2006
Chimeric Antigen Receptor Therapy
2018 Standout
The Role of DNA Methylation in Mammalian Epigenetics
2001 StandoutScience
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia
2002
ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach.
2000
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
2014
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
1998
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
2012
Works of Jeanette Pullen being referenced
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
2015
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201
2007
Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
2008
Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and down's syndrome. A pediatric oncology group study
1991
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report
2000
Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994
2000
Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis--a Pediatric Oncology Group Study.
1988
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
1996
Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions
1997
Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia
2001
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
1993
Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group
2009
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
1999
Skin Microvascular Architecture and Perfusion Studied in Human Postmastectomy Oedema by Intravital Video-Capillaroscopy
1994
Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
2006
Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication.
2001
Isolated CNS Relapse of Acute Lymphoblastic Leukemia Treated With Intensive Systemic Chemotherapy and Delayed CNS Radiation: A Pediatric Oncology Group Study
2006
Effect of trimethoprim/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia a pediatric oncology group study
1987
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study
1992
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study
1999
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study
1992
Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
1997
Comparison of prednisolone, vincristine, methotrexate, and 6-mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia
1975
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
1999
Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study
1986
Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).
2007